JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 2.190
-0.030 (-1.35%)
Nov 3, 2026, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 888.91 million as of November 2, 2026. It is the 24,236th most valuable company in the world and the 1,163rd biggest in Hong Kong. Its market cap has decreased by 37.03% in one year.
Market Cap
888.91M
Enterprise Value
730.34M
Revenue
333.25M
Global Rank
Country Rank
#1,163 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 888.91M, a decrease of -89.26%. That is a compound annual growth rate of -31.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 888.91M | -12.69% |
| Dec 31, 2025 | 1.02B | 96.55% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.24B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.20B |
| Cloudbreak Pharma | 1.10B |
| TYK Medicines | 1.10B |
| Zhaoke Ophthalmology | 1.09B |
| CANbridge Pharmaceuticals | 1.03B |
| Sunho Biologics | 970.43M |
| Wuhan YZY Biopharma | 775.40M |